Welcome to our dedicated page for Astera Labs SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astera Labs filings document a Nasdaq-listed semiconductor connectivity company serving rack-scale AI infrastructure. The company’s Form 8-K reports cover quarterly and annual operating results, product and demand commentary tied to PCIe 6, Scorpio smart fabric switches, signal conditioning and Smart Cable Modules, and material business updates.
ALAB regulatory disclosures also record its common stock listing on the Nasdaq Global Select Market, emerging growth company status, executive officer appointments and compensation arrangements, and material definitive agreements, including customer-linked warrant terms. Proxy materials describe annual meeting proposals, board elections, auditor ratification, executive compensation votes and stockholder voting mechanics.
Astera Labs, Inc. submitted a Form 144 notice reporting proposed sales of Common Stock tied to the vesting of restricted stock units on 02/15/2026.
The filing lists prior sales by Philip Mazzara: 4,620 shares on 11/17/2025 and 10,000 shares on 01/02/2026. The cover block shows 168,903,616 shares outstanding as of 02/17/2026.
Astera Labs filed a Form 144 disclosing a sale of 11,430 shares of common stock by Michael Truett Tate on 11/17/2025. The filing also records a vesting of restricted stock units on 02/15/2026 and identifies Morgan Stanley Smith Barney LLC as the broker.
Astera Labs insider filing to sell shares. The Form 144 discloses an intended sale of 94,971 shares of common stock tied to the vesting of restricted stock units on 02/15/2026. The filing lists a prior sale of 90,459 shares on 11/17/2025.
Astera Labs disclosed a proposed sale of 94,971 shares of common stock tied to the vesting of restricted stock units on 02/15/2026. The filing also shows a prior sale of 90,459 shares on 11/17/2025 reported by Jitendra Mohan. The notice lists the transaction as an issuer-related vesting event.
Astera Labs, Inc. reported an equity award for its Chief Financial Officer, Tate Michael Truett. On February 6, 2026, he received 11,787 restricted stock units of Common Stock at a price of $0 per share, increasing his directly held Common Stock to 204,084 shares.
The RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, conditioned on his continued service. Separately, 450,281 Common Stock shares are held indirectly by the Tate 1997 Living Trust, where he is a trustee and disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. insider filing shows new equity compensation for a senior executive. President and COO, and director, Gajendra Sanjay received 26,522 restricted stock units (RSUs) of common stock on February 6, 2026 at a stated price of $0.
The RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, contingent on his continued service. Following this award, he directly beneficially owns 1,626,272 common shares. Additional common shares are held through three separate estate-planning trusts, where he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. reported an equity grant to its Chief Executive Officer and director, Mohan Jitendra. On February 6, 2026, he received 26,522 shares of common stock as restricted stock units at $0 per share under the 2024 Stock Option and Incentive Plan.
The RSUs vest as to 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, contingent on continued service. Following this grant, he directly holds 1,547,710 shares of common stock. Additional common shares are held indirectly through a living trust and several estate-planning trusts that are associated with him, for which he disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. reported that its General Counsel and Secretary, Philip Mazzara, received an equity award in the form of restricted stock units. On February 6, 2026, he was granted 5,893 RSUs at a price of $0 per share under the 2024 Stock Option and Incentive Plan.
These RSUs vest 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, as long as he continues his service with the company. Each RSU converts into one share of common stock upon vesting, bringing his directly owned common shares to 142,933 after this grant.
Astera Labs, Inc. announced that Chief Financial Officer Michael Tate will retire from the CFO role effective March 2, 2026, and will remain with the company as Strategic Advisor to the CEO until September 1, 2026 under a transition services agreement. The company states there were no disagreements with Mr. Tate and that his retirement is not related to its operations, policies, or practices.
The board appointed Desmond Lynch as the new Chief Financial Officer effective March 2, 2026. His offer letter provides a $500,000 annual base salary, an annual target bonus equal to 95% of base salary, and equity awards comprising $6,000,000 in restricted stock units, a $1,000,000 supplemental RSU grant, and $2,000,000 in performance stock units, all subject to time-based or performance-based vesting and continued employment.
Astera Labs reported a breakout 2025 with rapid AI-driven growth. Fourth-quarter revenue reached $270.6 million, up 17% sequentially and 92% year-over-year, with GAAP gross margin of 75.6% and GAAP net income of $45.0 million, or $0.25 per diluted share.
For full-year 2025, revenue rose 115% year-over-year to $852.5 million, with GAAP net income of $219.1 million and diluted EPS of $1.22. Non-GAAP operating margin was 39.2%, reflecting substantial profitability after excluding stock-based compensation and acquisition costs.
The company is ramping its Scorpio X-Series smart fabric switches with hyperscaler customers, expanding custom NVLink Fusion connectivity, and launching Leo CXL Smart Memory Controllers. For Q1 2026, it guides revenue to $286–$297 million and GAAP diluted EPS of $0.36–$0.38, with non-GAAP EPS of $0.53–$0.54.